Skip to content
Cell Supply
Products
Ncyte® Microglia
Ncyte® Heart in a Box™
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC Reprogramming
iPSC Gene Editing
iPSC Differentiation
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Cell Supply
Products
Ncyte® Microglia
Ncyte® Heart in a Box™
Ncyte® vCardiomyocytes
Ncyte® aCardiomyocytes
Ncyte® Astrocytes
Ncyte® Endothelial Cells
Ncyte® Smooth Muscle Cells
Upcoming products
Custom Supply
iPSC Reprogramming
iPSC Gene Editing
iPSC Differentiation
Discovery Services
Solutions
Ready-to-Use Assays
Custom Screening Services
Overview Assay Capabilities
Modalities
Small Molecule
RNA Therapy
Gene Therapy
Biologics
Regenerative Medicine
Our Approach
iPSC Technology
Insights
Resources
Webinars
News
Events
About
Company
Team
Careers
Contact
Search
Search
HOME
insights
news
Ncardia News
Stay up-to-date with the latest news, trends and developments in iPSCs.
Filter
All
News
Press Release
press release
January 21, 2020
Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes
Ncardia Stem Cell Experts
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
